ESR1 and breast carcinoma: An example is represented by the persistence of elevated levels of U6 in the plasma of ER+ and ER-breast cancer patients, both active and inactive, but not in healthy cases; this evidence hence indicates an increased polymerase III activity in breast tumors, regardless of the disease progression (166, 167).